BeStock  
Stocks › Biotechnology › IMTX

Immatics IMTX

US equityMarket cap rank #3243Biotechnology
$5.77 −$0.18 (-3.03%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $5.88 +1.91%
Open$5.86
Prev close$5.95
Day range$5.72 – $5.95
Volume746.7K
Market cap$878.58M
P/E (TTM)–
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership88.3%+1.04 pts vs. prior quarter
Institutions holding99+2 vs. prior quarter
Insider trades (recent)12 buys / 0 sellsNet buying
Short interest2.45% of floatDays to cover 3.0 · as of 30 Oct 2026
Short-sale volume share11.8%5-day average of daily volume

Short-sale volume as % of daily volume

5%9%13%18%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: −$4.02M (5 inflow days, 15 outflow days).

Net flow by order size, last 20 sessions

−$2.6MSuper−$1.4MBig−$4.3MMid−$2.1MSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 53.4% of shares outstanding.

Largest holders

  • T. Rowe Price Group, Inc.16.66%
  • dievini Hopp BioTech holding GmbH & Co. KG10.90%
  • RTW Investments, LP9.47%
  • Perceptive Advisors LLC8.19%
  • Montanova Capital, LLC8.19%
  • Baker Bros. Advisors LP6.96%
  • Jefferies Financial Group Inc.4.70%
  • Vestal Point Capital, LP4.52%

By investor type

  • Hedge Fund34.31%
  • Mutual Fund24.22%
  • VC/PE Fund21.80%
  • Public Company6.77%
  • Individual/Insider3.45%
  • Private Company0.68%
  • Government Pension Fund0.51%
  • Sovereign Wealth Fund0.00%

Reported short interest has fallen from 3.60% to 2.45% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
abrdn plc Mutual Fund 2026/Q3 +581,856 0.9%
Jane Street Group, LLC Private Company 2026/Q3 +295,113 0.3%
Hartford Funds Management Company, LLC Mutual Fund 2026/Q3 +219,487 0.2%
Morgan Stanley Public Company 2026/Q3 +126,406 1.7%
Morgan Stanley Investment Management Inc. Mutual Fund 2026/Q3 +126,406 1.7%
Y-Intercept (Hong Kong) Limited Mutual Fund 2026/Q3 +121,475 0.1%
BlackRock Mutual Fund 2026/Q3 +81,273 0.1%
ALPS Advisors, Inc. Mutual Fund 2026/Q3 +62,640 0.1%
Squarepoint OPS LLC Hedge Fund 2026/Q3 +56,896 0.0%
Doliver Advisors, L.P. Mutual Fund 2026/Q3 +30,000 0.0%
Hartford Funds Management Company, LLC Mutual Fund 2026/Q3 +219,487 0.2%
Perceptive Advisors LLC VC/PE Fund 2026/Q3 +815,060 8.2%
Jefferies Financial Group Inc. Public Company 2026/Q3 +1,447,251 4.8%
Boxer Capital Management, LLC Hedge Fund 2026/Q3 +475,000 0.3%
T. Rowe Price Group, Inc. Mutual Fund 2026/Q3 +471,426 16.7%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
25 Aug 2026 Perceptive Advisors LLC Private Acquisition +863,060 $8.69 11,246,516
13 Aug 2026 James Pepin General Counsel Other Derivative Acquisition +43,800 – 43,800
13 Aug 2026 James Pepin General Counsel Other Derivative Acquisition +181,200 $9.44 181,200
15 Jun 2026 Michael Atieh Independent Non-Executive Director Other Derivative Acquisition +48,000 $9.09 48,000
15 Jun 2026 Peter Chambré Non-Executive Chairperson Other Derivative Acquisition +48,000 $9.09 48,000
15 Jun 2026 Heather Mason Independent Vice Chair of the Board of Directors Other Derivative Acquisition +48,000 $9.09 48,000
15 Jun 2026 Perceptive Advisors LLC Other Derivative Acquisition +48,000 $9.09 48,000
15 Jun 2026 Eliot Forster Independent Non-Executive Director Other Derivative Acquisition +48,000 $9.09 48,000
15 Jun 2026 Paul Carter Independent Non-Executive Director Other Derivative Acquisition +48,000 $9.09 48,000
15 Jun 2026 Mathias Hothum Non-Executive Director Other Derivative Acquisition +48,000 $9.09 48,000
15 Jun 2026 Alise Reicin Non-Executive director Other Derivative Acquisition +48,000 $9.09 48,000
15 Jun 2026 Adam Stone Independent Non-Executive Director Other Derivative Acquisition +48,000 $9.09 48,000
17 Mar 2026 Michael Atieh Independent Non-Executive Director Initial Statement of Beneficial +0 – 171,500
17 Mar 2026 Peter Chambré Non-Executive Chairperson Initial Statement of Beneficial +0 – 383,474
17 Mar 2026 Heather Mason Independent Vice Chair of the Board of Directors Initial Statement of Beneficial +0 – 171,500
17 Mar 2026 Perceptive Advisors LLC Initial Statement of Beneficial +0 – 10,383,456
17 Mar 2026 Harpreet Singh CEO, MD, Member of Management Board & Executive Director Initial Statement of Beneficial +0 – 4,509,684
17 Mar 2026 Carsten Reinhardt Chief Development Officer Initial Statement of Beneficial +0 – 1,065,501
17 Mar 2026 Eliot Forster Independent Non-Executive Director Initial Statement of Beneficial +0 – 171,500
17 Mar 2026 Paul Carter Independent Non-Executive Director Initial Statement of Beneficial +0 – 171,500

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 3,669,476 2.5% 3.0
15 Oct 2026 3,747,677 2.5% 3.7
30 Sep 2026 3,690,633 2.5% 4.2
15 Sep 2026 4,438,234 3.0% 8.3
31 Aug 2026 4,853,483 3.2% 6.4
14 Aug 2026 4,921,838 3.6% 14.9

Discussion

No comments yet — be the first to weigh in on IMTX.

Sign in to join the discussion.

Scroll to Top